Proceedings of the National Academy of Sciences · 1995 · 481 citations · 35 references
Life SciencesCell BiologyImmunologyCell AdhesionInflammationMolecular ImmunologyCytokine BiologyEndothelial ActivationInflammatory MediatorsInflammatory SignalingLeukocyte AdhesionLeukocyte RecruitmentCellular Adhesion Molecule ExpressionEndothelial Adhesion MoleculesEndothelial InflammationEndothelial-leukocyte InteractionsIntercellular Adhesion Molecule 1Leukocyte Adhesion MoleculesLeukocyte-endothelium InteractionsVascular Cell Adhesion Molecule 1
Cultured human umbilical vein endothelial cells (EC) constitutively express a low level of CD40 antigen as detected by monoclonal antibody binding and fluorescence flow cytometric quantitation. The level of expression on EC is increased about 3-fold following 24 h treatment with optimal concentrations of tumor necrosis factor, interleukin 1, interferon beta, or interferon gamma; both interferons show greater than additive induction of CD40 when combined with tumor necrosis factor or interleukin 1. Expression of CD40 increases within 8 h of cytokine treatment and continues to increase through 72 h. A trimeric form of recombinant murine CD40 ligand acts on human EC to increase expression of leukocyte adhesion molecules, including E-selectin, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1. CD40 may be detected immunocytochemically on human microvascular EC in normal skin. We conclude that endothelial CD40 may play a role as a signaling receptor in the development of T-cell-mediated inflammatory reactions.
35
Molecular and biological characterization of a murine ligand for CD40
Richard J. Armitage, William C. Fanslow, L Strockbine et al. · Nature · 1992 · 1K citations
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
R.Cutler Allen, Richard J. Armitage, Mary Ellen Conley et al. · Science · 1993 · 827 citations
Life Sciences, Genetics, Immunology +17